Do statins still offer meaningful protection against cardiovascular disease as people grow older? A landmark Australian trial has provided some clarity.

Research has linked shingles vaccination to reduced dementia risk. Could more vaccines reduce the risk of non-infectious diseases?

With pharmacists taking on more advanced roles than ever, PSA’s revised Code of Ethics for Pharmacists sets out accountability.

Cannabis use is linked to significantly earlier onset of psychosis, and age is a key factor – found new research from the University of New South Wales.

Long before it became a standard patch for travel sickness, scopolamine was at the centre of a controversial obstetric practice.

Illegal peptide products pushed through social media are promising to improve Australians’ looks and libidos, increase muscle tone or fight the effects of ageing...

When patients seek advice about illicit substances, pharmacists must balance harm reduction and safety with non-judgemental care.

A new therapy can delay progression to insulin-dependent type 1 diabetes.

Emerging models are focusing on HIV, viral hepatitis and STI care in community pharmacy settings to ensure more effective patient care.

One of the last emergency measures from the pandemic-era COVID-19 response is transitioning.